BALL score predicts benefit from ibrutinib therapy in relapsed/refractory CLL patientsAugust 11, 2020Leukemia, Myelodysplasia, Transplantation
Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapyAugust 7, 2020Leukemia, Myelodysplasia, Transplantation
Hepatitis screening now for all patients with cancer on therapyAugust 6, 2020Patient & Survivor CareCNS/Brain CancerBreast CancerGynecologic CancerGastroenterologyGenitourinary CancerHead & Neck/Thyroid Cancers
ASCO says ‘no’ to home infusions of cancer treatment, with exceptionsAugust 5, 2020Patient & Survivor CareCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
OK to treat many cancer patients despite pandemic, says ESMOJuly 31, 2020Patient & Survivor CareCOVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic Cancer
CCC19, other registries help define COVID/cancer landscapeJuly 27, 2020Patient & Survivor CareLung CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersCOVID-19 UpdatesGastroenterologyGenitourinary Cancer
In remission for 10 years: Long-term toxicity data on CAR T cellsJuly 21, 2020Leukemia, Myelodysplasia, Transplantation
Don’t overlook treating older patients with acute promyelocytic leukemia, expert saysJuly 17, 2020Leukemia, Myelodysplasia, Transplantation
FDA approves oral therapy for myelodysplastic syndromes, CMMLJuly 8, 2020Leukemia, Myelodysplasia, Transplantation
Combo drug improves survival in older patients with high-risk/secondary AMLJune 26, 2020Leukemia, Myelodysplasia, Transplantation
Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AMLJune 25, 2020Leukemia, Myelodysplasia, Transplantation
HSCT may be best option for therapy-related ALLJune 24, 2020Leukemia, Myelodysplasia, Transplantation
Ibrutinib-venetoclax produces high MRD-negative rates in CLL/SLLJune 23, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
First-in-kind anti-CD47 antibody shows promise for MDS and AML treatmentJune 19, 2020Leukemia, Myelodysplasia, Transplantation
